Chapter 5 — Molecular Biology

Basic chemical units: Nucleic acids are long polymers made from repeating units called nucleotides. Each nucleotide contains three parts: a five-carbon sugar, a phosphate group and a nitrogen-containing base. The sugar is ribose in RNA and deoxyribose in DNA; the latter lacks a 2'-OH and so is chemically more stable. The bases belong to two families: purines (adenine and guanine) which have a two-ring structure, and pyrimidines (cytosine, thymine in DNA and uracil in RNA) with a single ring. The identity and order of these bases along the polymer carry genetic information.

Covalent linkages and polarity: Nucleotides are joined by phosphodiester bonds between the 3'-hydroxyl group of one sugar and the 5'-phosphate of the next. This linkage gives the strand directionality: one end is the 5' phosphate and the other is the 3' hydroxyl. Enzymes that synthesise nucleic acids always work in a defined direction (5'→3'), because they add a nucleotide to the free 3'-OH of the growing chain.

Base pairing and hydrogen bonds: In double-stranded DNA bases form specific hydrogen bonds: adenine pairs with thymine (two hydrogen bonds) and guanine pairs with cytosine (three hydrogen bonds). In RNA, uracil replaces thymine. Complementary base pairing allows strands to form predictable double-stranded structures and is the chemical basis for replication, transcription and many hybridisation techniques used in the lab.

Physical properties and stability: The sugar-phosphate backbone is negatively charged because of phosphate groups; this makes nucleic acids soluble in water and able to interact with positively charged proteins and ions (Mg2+, Na+). The double helical arrangement of DNA stacks hydrophobic bases inside and keeps polar backbone outside, contributing to structural stability. RNA’s extra 2'-OH makes it more reactive and capable of folding into complex three-dimensional shapes used for catalysis and regulation (ribozymes and riboswitches).

Functional roles of nucleotides beyond polymers: Free nucleotides play many roles — ATP is the universal energy currency, GTP is involved in signalling and translation, cyclic AMP acts as a second messenger in signal transduction, and NAD+/FAD act as redox cofactors in metabolism. Thus nucleotide chemistry underlies both genetic information flow and core metabolic activities.

Biological importance: Mastering nucleotide structure, bonding and properties gives students the tools to understand how enzymes recognise sequences, how mutations alter function, how complementary probes work in diagnostics, and why certain lab procedures (like alkaline hydrolysis of RNA) affect nucleic acids differently. These fundamentals are the foundation for the rest of molecular biology.

Overview of the double helix: The canonical structure of DNA in cells is a right-handed double helix where two antiparallel polynucleotide chains wind around a central axis. The sugar-phosphate backbones form the outside framework and the nitrogenous bases face inwards, forming base pairs that stack like steps of a spiral staircase. The double helix is not merely a static ladder; its geometry and chemistry explain replication fidelity, protein interactions and packaging.

Antiparallel orientation and directionality: The two strands run in opposite directions: one strand has a 5'→3' orientation while the complementary strand runs 3'→5'. This antiparallel arrangement is essential because hydrogen bonding between complementary bases requires the correct orientation and because DNA-processing enzymes are directional — DNA polymerases add nucleotides only at a free 3'-OH, so strand polarity determines how replication and repair proceed.

Major and minor grooves: The pairing geometry creates alternating major and minor grooves along the helix. These grooves expose different patterns of hydrogen bond donors and acceptors and allow proteins such as transcription factors, restriction enzymes and polymerases to 'read' sequence information without unwinding the helix. Many regulatory proteins contact bases in the major groove where sequence-specific recognition is easier; other proteins bind the minor groove or interact primarily with the sugar-phosphate backbone.

Stabilising interactions: Hydrogen bonds between complementary bases provide specificity, but much of the helix stability comes from base stacking interactions — hydrophobic and van der Waals forces among aromatic bases. The hydrophobic interior repels water and causes bases to stack tightly, stabilising helical structure. Electrostatic interactions between negatively charged phosphates and positively charged ions and proteins also influence conformation and stability; Mg2+ and K+ are common stabilising cations in cells.

Conformational variants: DNA can adopt multiple conformations depending on sequence and environment. B-DNA is the most common physiological form: a right-handed helix with about 10.5 base pairs per turn. A-DNA, also right-handed, appears under dehydrating conditions and in RNA–DNA hybrids; it is shorter and broader. Z-DNA is a left-handed zigzag form that can occur in sequences with alternating purines and pyrimidines and may play roles in regulation and genome dynamics. Local deviations from ideal geometry (bends, kinks, unwinding) are biologically significant — for example, promoter regions or protein-binding sites often cause DNA bending.

Biological implications: The double-helix model explains how information is stored (via linear base sequence), faithfully copied (complementary templating), and accessed (groove recognition and controlled unwinding). Understanding helical structure helps in comprehending the action of enzymes (polymerases, nucleases, topoisomerases), the effects of mutations (base substitutions destabilise local pairing), and the physical basis for chromosome compaction and gene regulation.

From DNA to chromatin: In eukaryotic cells, metres of DNA are compacted into a nucleus by associating with proteins to form chromatin. The organisation of chromatin is hierarchical and dynamic, balancing the need for compaction with accessibility for transcription, replication and repair. The fundamental repeating unit is the nucleosome: about 147 base pairs of DNA wrapped ~1.65 turns around an octamer of histone proteins (two each of H2A, H2B, H3 and H4). The nucleosome resembles beads on a string under low salt conditions.

Histone structure and interactions: Histones are small, positively charged proteins whose N-terminal tails protrude from the nucleosome core. These tails are sites for post-translational modifications (acetylation, methylation, phosphorylation, ubiquitination) that change how tightly DNA binds histones or recruit effector proteins. For example, histone acetylation neutralises positive charges on lysine residues, decreasing histone-DNA attraction and opening chromatin to transcription.

Higher-order folding: Nucleosomes fold into a more compact 30 nm fibre (structure debated) and further form loops anchored to a protein scaffold to create chromatin domains. During interphase, chromatin is organised into euchromatin (less condensed, gene-rich, transcriptionally active) and heterochromatin (dense, transcriptionally silent, often repetitive). Chromosome territories refer to non-random spatial localisation of chromosomes within the nucleus, influencing gene expression by positioning genes near regulatory hubs or the nuclear periphery.

Packaging and function trade-offs: Packaging protects DNA and coordinates large-scale processes but restricts access. Cells use chromatin remodellers (ATP-dependent complexes) to reposition or eject nucleosomes, thereby exposing promoter regions when required. Epigenetic modifications on histones and DNA methylation add regulatory layers; they can be mitotically heritable and influence cell fate decisions without altering DNA sequence.

Prokaryotic differences: Bacteria compact their DNA in a nucleoid without nucleosomes. They use DNA supercoiling, nucleoid-associated proteins (e.g., HU, IHF) and transcription-translation coupling to organise the genome. Supercoiling topology affects promoter activity and accessibility.

Chromosome condensation in the cell cycle: During mitosis, chromatin condenses further with the aid of structural proteins like condensins to form visible metaphase chromosomes necessary for faithful segregation. Errors in packaging, histone modification or chromosome segregation can cause genomic instability and disease. Understanding chromatin organisation thus links molecular structure to gene regulation, cell identity and genome maintenance.

Purpose and fidelity: DNA replication duplicates the genome before cell division so that each daughter cell inherits a full complement of genetic information. The process must be highly accurate to prevent mutations that can impair cell function or cause disease. Accuracy is achieved through base-pairing rules, proofreading by DNA polymerases and subsequent repair pathways.

Historical models and evidence: Early models included conservative replication (parental strands remain together), dispersive replication (parental and new DNA interspersed), and semiconservative replication (each daughter duplex contains one parental and one new strand). Experimental evidence using density labelling showed the semiconservative model is correct for cellular DNA. Understanding the model clarifies why each daughter molecule retains one template strand and one newly synthesised strand.

Origins and initiation: Replication begins at specific sequences called origins of replication. Prokaryotes like E. coli typically have a single origin (oriC), while eukaryotic chromosomes have many origins spaced along the chromosome to allow rapid duplication of large genomes. Initiator proteins recognise origins and recruit helicases and other factors to form pre-replication complexes in a regulated manner during the cell cycle, ensuring replication occurs once per cycle.

Replication fork dynamics: From an origin, two replication forks form that move bidirectionally. Each fork contains the machinery to unwind DNA, stabilise single strands, lay down primers and synthesise new DNA. Because DNA polymerases synthesise only in the 5'→3' direction while the two template strands are antiparallel, synthesis is continuous on the leading strand (in the direction of fork movement) and discontinuous on the lagging strand (opposite direction). The lagging strand is synthesised as short Okazaki fragments, each initiated by an RNA primer; these are later processed and joined.

Semidiscontinuous nature and processing: The semidiscontinuous mechanism refers to continuousleading and discontinuous lagging strand synthesis. Removal of RNA primers and replacement by DNA is crucial: RNase H or specific exonucleases remove the RNA, DNA polymerase fills the gap and DNA ligase seals the nick, restoring a continuous phosphodiester backbone. Topological stress from unwinding is relieved by topoisomerases that transiently cut DNA strands to relieve supercoils and then rejoin them, preventing breakage or torsional strain that would stall forks.

Regulation and checkpoints: Replication initiation and progression are tightly regulated. In eukaryotes, licensing factors ensure origins fire only once per cycle; replication stress activates checkpoints (ATR/ATM pathways) that halt cell cycle progression and stabilise forks, allowing repair before mitosis. This prevents incomplete or damaged genomes from being passed on. Overall, the combination of directional synthesis, proofreading, repair and checkpoint control produces a reliable system for genetic inheritance.

Collaborative machinery: DNA replication is carried out by a coordinated set of specialised enzymes and accessory proteins that assemble at the replication fork. No single enzyme can perform all tasks; instead, a replisome complex ensures unwinding, priming, synthesis, proofreading and ligation occur in the right order and at the right speed. Understanding these proteins illuminates how replication proceeds and how drugs or mutations can disrupt the process.

Helicase and single-strand binding proteins: Helicase is a motor protein that uses ATP hydrolysis to separate the two DNA strands ahead of the fork, creating a replication bubble. The exposed single strands are prone to re-annealing and nuclease attack; single-strand binding proteins (SSBs in bacteria, RPA in eukaryotes) bind and stabilise them, preventing secondary structures and protecting the template for polymerases.

Primase and primers: DNA polymerases cannot initiate new strands de novo; they require a short RNA primer with a free 3'-OH. Primase is an RNA polymerase that synthesises these primers. In prokaryotes primase is a single enzyme synthesising short primers; in eukaryotes primase activity is associated with DNA polymerase alpha which lays down an RNA–DNA hybrid primer for subsequent extension by more processive polymerases.

Replicative DNA polymerases: In bacteria DNA polymerase III holoenzyme is the main replicative polymerase with high processivity due to a sliding clamp (beta clamp) that tethers it to DNA. It has 3'→5' exonuclease proofreading that removes misincorporated nucleotides. DNA polymerase I removes RNA primers with 5'→3' exonuclease activity and fills gaps. In eukaryotes several polymerases share tasks: polymerase alpha (primase-coupled) initiates synthesis; polymerase delta primarily synthesises lagging strand; polymerase epsilon mainly synthesises leading strand. RFC loads the sliding clamp (PCNA in eukaryotes) to increase processivity, and various clamp loaders coordinate polymerase switching.

Topoisomerases and other helpers: Unwinding the helix ahead of the fork introduces positive supercoiling; topoisomerases (type I and II) relieve this tension by creating transient single- or double-strand breaks and re-ligating DNA. Without them replication forks would stall and break. DNA ligase seals nicks in the sugar-phosphate backbone, joining Okazaki fragments to create continuous strands. Repair proteins and mismatch repair factors follow replication to correct remaining errors.

Coordination and regulation: The replisome coordinates leading- and lagging-strand polymerases so synthesis proceeds smoothly despite their different modes. Checkpoint proteins sense replication stress and coordinate repair or slow fork progression. Many antibiotics and anti-cancer drugs target replication proteins — for example, quinolones inhibit bacterial topoisomerases and certain nucleoside analogues inhibit viral polymerases — illustrating the central biological and clinical importance of these replication proteins.

Central process: Transcription is the copying of genetic information from DNA into RNA. It is the first step in gene expression and provides a flexible layer where regulation can determine which genes are expressed, when and to what extent. RNA molecules produced serve diverse roles: mRNA for protein coding, rRNA and tRNA for translation machinery, and many regulatory non-coding RNAs that control gene expression.

Enzyme and directionality: RNA polymerase catalyses RNA synthesis using ribonucleotide triphosphates (rNTPs) and reads the DNA template strand in a 3'→5' direction, synthesising RNA in the 5'→3' direction. Unlike DNA polymerase, most RNA polymerases can initiate de novo without a primer. Transcription produces an RNA molecule complementary to the template strand and identical in sequence (except T→U) to the coding (non-template) strand.

Promoters, initiation and regulatory proteins: Transcription begins at promoter sequences upstream of genes. In prokaryotes, a sigma factor recognises specific promoter motifs (-35 and -10 elements) and guides RNA polymerase to the start site. After initiation, sigma may dissociate and elongation continues. Eukaryotes have greater complexity: general transcription factors (TFIID, TFIIA, TFIIB, etc.) assemble with RNA polymerase II at core promoter elements (like the TATA box) to form a pre-initiation complex. Activators and repressors bind enhancers or silencers to modulate promoter activity, often by recruiting co-activators that modify chromatin to permit or block access.

Elongation mechanics and transcription bubble: During elongation the RNA polymerase moves along DNA, maintaining a small transcription bubble (about 12–14 bp) where the template strand is exposed and an RNA-DNA hybrid forms briefly. The enzyme proofreads by backtracking occasionally and using intrinsic hydrolytic activity or associated factors to remove misincorporated nucleotides. Elongation rate and pausing influence co-transcriptional processes such as splicing and termination.

Termination strategies: Termination differs among organisms. In bacteria, intrinsic termination relies on an RNA hairpin followed by a U-rich tract causing polymerase release; rho-dependent termination uses a helicase that dislodges the polymerase. Eukaryotic RNAPII termination involves recognition of polyadenylation signals; cleavage of the nascent transcript followed by exonuclease-mediated 'torpedo' of the leftover RNA fragment promotes polymerase release. Different termination mechanisms affect transcript stability and processing.

Multiple RNA polymerases and RNA types: In eukaryotes distinct RNA polymerases transcribe specific classes of genes: RNA polymerase I makes rRNA precursors (except 5S rRNA), RNAPII synthesises mRNA and many snRNAs, and RNAPIII makes tRNAs and 5S rRNA. This division allows differential regulation and specialised processing pathways. Together, transcription and its regulation enable cells to respond dynamically to developmental cues and environmental changes.

Why processing is required: In eukaryotic cells, primary transcripts produced by RNA polymerase II (pre-mRNAs) undergo several processing steps before they can serve as templates for translation. Processing increases mRNA stability, promotes correct export from the nucleus to the cytoplasm, helps ribosomes recognise transcripts and allows additional regulation such as alternative splicing that increases protein diversity from a single gene.

5' capping mechanism and function: Soon after transcription initiation, the nascent RNA receives a 5' cap: a 7-methylguanosine linked via a 5'–5' triphosphate bridge to the first nucleotide. Capping protects the transcript from exonucleases, facilitates splicing of the first intron, and is recognised by the cap-binding complex and translation initiation factors, which promote ribosome recruitment and efficient translation.

Splicing and the spliceosome: Many eukaryotic genes are interrupted by introns—non-coding sequences that must be removed. Splicing is performed by the spliceosome, a large ribonucleoprotein complex composed of small nuclear RNAs (snRNAs) and proteins. The spliceosome recognises conserved sequence motifs at 5' splice sites (GU), branch point sequences and 3' splice sites (AG), catalyses two transesterification reactions to remove the intron as a lariat structure and ligates exons together. Accurate splicing depends on correct recognition of splice sites and auxiliary signals; errors can cause exon skipping or intron retention with potential disease consequences.

Alternative splicing and regulation: Alternative splicing allows a single pre-mRNA to be processed in multiple ways, generating different mRNA isoforms that encode proteins with distinct domains or regulatory properties. Tissue-specific splicing factors and signalling-dependent modifications of splicing proteins determine alternative splicing patterns during development and in response to signals, greatly expanding the proteome complexity in multicellular organisms.

3' end formation and polyadenylation: Co-transcriptionally, cleavage of the nascent pre-mRNA occurs downstream of a polyadenylation signal sequence (AAUAAA). Following cleavage, poly(A) polymerase adds a poly(A) tail of adenine residues to the 3' end. The poly(A) tail, bound by poly(A) binding proteins, enhances mRNA stability, aids nuclear export and promotes translation initiation in the cytoplasm. Alternative polyadenylation can change UTR length and affect mRNA stability and regulation by miRNAs.

Other RNA maturation events: rRNA and tRNA precursors are processed by specific endo- and exonucleases and modified at particular bases and riboses (methylation, pseudouridylation) required for proper folding and function in translation. Small regulatory RNAs such as miRNAs and siRNAs are generated by dedicated pathways (Drosha and Dicer in animals) and participate in post-transcriptional gene silencing. Collectively, these processing steps create mature RNAs competent for their cellular roles and provide multiple checkpoints for regulation and quality control.

Overview: Translation is the process by which ribosomes read the sequence of an mRNA and synthesise the corresponding polypeptide. It converts genetic information from nucleic acid language (codons) into amino acid sequences. This process is universal across life with variations in initiation mechanisms, and it involves tRNAs, aminoacyl-tRNA synthetases, ribosomes, and numerous protein factors that ensure accuracy and efficiency.

Genetic code properties: The genetic code is read in non-overlapping triplets (codons) and maps 64 codons to 20 amino acids plus stop signals. The code is nearly universal, degenerate (multiple codons code for the same amino acid), and unambiguous (each codon specifies a single amino acid or stop). The start codon (usually AUG) not only codes for methionine but also sets the reading frame. Stop codons (UAA, UAG, UGA) signal termination and are recognised by release factors rather than tRNAs.

tRNA structure and charging: tRNAs are small RNAs with a cloverleaf secondary structure and an L-shaped three-dimensional fold. An anticodon triplet in the tRNA pairs with the mRNA codon, while the 3' acceptor arm is covalently linked to a specific amino acid by an aminoacyl-tRNA synthetase. Each synthetase recognises one amino acid and its corresponding tRNAs, performing an ATP-dependent charging reaction that is a key accuracy checkpoint—incorrect charging leads to mistranslation.

Ribosome architecture and sites: Ribosomes are ribonucleoprotein complexes composed of large and small subunits (50S/30S in bacteria; 60S/40S in eukaryotes). They present three tRNA binding sites: the A (aminoacyl) site for incoming charged tRNAs, the P (peptidyl) site holding the tRNA with the growing peptide, and the E (exit) site for discharged tRNAs. The ribosome catalyses peptide bond formation via peptidyl transferase activity primarily carried out by rRNA, making the ribosome a ribozyme.

Stages of translation: Initiation assembles the ribosomal subunits at the start codon with initiator tRNA (fMet-tRNA in bacteria, Met-tRNAi in eukaryotes) and initiation factors that position the complex correctly. Elongation involves cycles of codon recognition, peptide bond formation and translocation: elongation factors (EF-Tu, EF-G in bacteria; eEF1, eEF2 in eukaryotes) deliver charged tRNAs and drive movement. Proofreading at the decoding center reduces errors. Termination occurs when a stop codon enters the A site; release factors promote hydrolysis of the polypeptide from the tRNA and disassembly of the complex. Post-translational folding and modifications (chaperone-assisted folding, cleavage of signal peptides, glycosylation, phosphorylation) are necessary for protein function and localisation.

Accuracy and regulation: Translation accuracy is crucial: errors can produce dysfunctional proteins. Cells regulate translation globally (e.g., via EIF2 phosphorylation) and specifically (via upstream open reading frames, miRNA-mediated repression, mRNA structure and codon usage). Practical understanding of translation assists in interpreting mutation effects, designing expression constructs for recombinant protein production and developing antibiotics that target bacterial translation.

Fundamental features: The genetic code is the set of rules translating sequences of three nucleotides (codons) into amino acids. Because there are four nucleotides, the number of possible triplets is 4^3 = 64, providing more codons than the 20 standard amino acids plus stop signals. The redundancy in the code is known as degeneracy: many amino acids are specified by multiple codons, particularly differing at the third, or wobble, position.

Start and stop codons and universality: AUG typically functions as the initiation codon and codes for methionine (and for N-formylmethionine in bacteria during initiation). Stop codons UAA, UAG and UGA terminate translation. The code is nearly universal across organisms, with a few notable exceptions in mitochondrial genomes and some protozoa where certain codons have been reassigned, illustrating evolutionary flexibility but also deep conservation.

Degeneracy and the wobble hypothesis: The wobble hypothesis explains why the third base of codons can often vary without changing the encoded amino acid. Flexible base pairing at the third position between codon and anticodon permits fewer tRNA species to decode all codons. For example, glycine is encoded by GGU, GGC, GGA and GGG; a single tRNA with an appropriate anticodon and wobble pairing can recognise more than one of these codons. This reduces the number of distinct tRNAs required and increases tolerance to certain point mutations.

Types of mutations and their consequences in coding sequences: Because of degeneracy, some point mutations are synonymous or silent (no change in amino acid); these often have little immediate effect, though they can alter translation efficiency or mRNA stability. Missense mutations change one amino acid to another; consequences depend on chemical nature and position in the protein. Nonsense mutations create premature stop codons leading to truncated proteins that are often nonfunctional or unstable. Insertions or deletions that are not in multiples of three cause frameshifts that alter the reading frame downstream and usually result in dramatically altered and nonfunctional proteins.

Practical implications: Knowledge of the genetic code allows prediction of polypeptide sequences from nucleotide sequences and vice versa. It underpins molecular cloning strategies (ensuring correct reading frame), design of expression constructs and codon optimisation to improve heterologous protein expression by matching codon usage to host tRNA abundance. Understanding codon usage bias and synonymous changes is also important in evolutionary studies and in designing silent mutations to alter regulatory motifs or reduce immune recognition in therapeutic proteins.

Rationale for regulation: Prokaryotic cells live in changing environments and must rapidly adapt by switching genes on or off. Because transcription and translation are coupled in bacteria, regulatory decisions at the level of transcription have immediate consequences for protein levels. Prokaryotic regulation is often efficient, using operons and simple regulatory proteins that act directly at promoters or operators to control transcription.

Operon structure and logic: An operon is a cluster of genes under the control of a single promoter that produces a polycistronic mRNA encoding multiple proteins with related functions (e.g., metabolic pathways). Operons include regulatory sequences like promoters and operators; regulatory proteins can bind these sequences to repress or activate transcription. This arrangement lets bacteria coordinate expression of entire pathways in response to environmental signals, conserving resources when those pathways are unnecessary.

Lac operon as a model of inducible regulation: The lac operon contains genes required for lactose uptake and digestion. In the absence of lactose, a repressor protein binds the operator and prevents RNA polymerase from transcribing structural genes. When lactose (actually allolactose, an isomer) is present, it binds the repressor and prevents operator binding, allowing transcription — this is induction. Additionally, catabolite repression couples sugar utilisation to preferred carbon sources: when glucose is scarce, cAMP levels rise, cAMP binds CRP (catabolite activator protein) and the complex activates the lac promoter, integrating signals about available nutrients.

Trp operon as a repressible system: The trp operon encodes enzymes for tryptophan biosynthesis. When tryptophan levels are high, tryptophan acts as a corepressor binding the trp repressor and enabling it to attach to the operator, blocking transcription. This negative feedback prevents wasteful synthesis. Some bacteria add attenuation: transcription is regulated by translation of a leader peptide and formation of alternative RNA secondary structures that terminate transcription prematurely when tryptophan is abundant.

Global control and two-component systems: Bacteria also use sigma factors to reprogram transcription under specific conditions (heat shock, stationary phase) where alternative sigma factors guide RNA polymerase to different promoter classes. Two-component regulatory systems consist of a membrane-bound sensor kinase that detects environmental signals and a response regulator that, when phosphorylated, alters gene expression. Such systems allow bacteria to sense and respond to a broad range of stimuli rapidly.

Practical relevance: Understanding prokaryotic regulation underlies antibiotic action, metabolic engineering in industrial microbes, and the design of synthetic genetic circuits. The relative simplicity of bacterial systems makes them powerful models for studying basic principles of gene control.

Greater complexity for multicellularity: Eukaryotic gene regulation supports cell differentiation, developmental programmes and complex responses to signals. Control occurs at many levels: chromatin accessibility, transcription initiation, RNA processing, mRNA export and stability, translation and post-translational modifications. This multilayered regulation allows precise spatial and temporal control of gene expression in tissues and during development.

Chromatin-based regulation and epigenetics: Chromatin structure is a primary regulator of transcriptional potential. Histone modifications such as acetylation generally correlate with active transcription by loosening nucleosome-DNA interactions and recruiting chromatin remodellers. Histone methylation can either activate or repress transcription depending on the residue modified. DNA methylation at CpG islands near promoters typically represses gene expression. These epigenetic marks can be stably maintained through cell divisions and contribute to cellular memory without altering the underlying DNA sequence.

Promoters, enhancers and long-range regulation: Core promoters near transcription start sites recruit the basal transcriptional machinery, but distal regulatory elements such as enhancers and silencers can dramatically influence transcriptional output. Enhancers bind combinations of transcription factors and co-activators and can act over long genomic distances by looping the DNA to contact promoter regions. Combinatorial control by multiple factors allows highly specific expression patterns and integration of different signalling inputs.

Transcription factors and signalling pathways: Transcription factors are proteins that recognise specific DNA motifs and recruit co-regulators that remodel chromatin or interact with RNA polymerase II. External signals (hormones, growth factors, stress) often act through signalling cascades that modify transcription factors (e.g., phosphorylation) or their localisation, thereby altering gene expression rapidly in response to the environment.

Post-transcriptional and translational control: Alternative splicing is widespread in eukaryotes and dramatically expands proteome diversity; it is regulated by spliceosomal components influenced by sequence elements and signalling pathways. MicroRNAs and RNA-binding proteins regulate mRNA stability and translation efficiency by binding to 3' UTRs. mRNA localisation and selective translation (for example, in oocytes or neurons) permit local protein synthesis that supports specialised cell functions.

Developmental and disease implications: Dysregulation of any regulatory layer can cause disease—mutations in transcription factors, epigenetic misregulation, aberrant splicing or miRNA function contribute to cancers, developmental disorders and metabolic diseases. Understanding eukaryotic regulation is therefore central to developmental biology, regenerative medicine and targeted therapies.

Definition and origins: A mutation is any change in the DNA sequence. Mutations arise spontaneously from errors during replication, spontaneous base deamination, tautomeric shifts, or reactive oxygen species; they can also be induced by external mutagens such as UV light, ionising radiation or chemical agents. The frequency and spectrum of mutations depend on organismal repair capacity, exposure history and cellular context.

Point mutations and small indels: Point mutations affect single nucleotides and include substitutions—transition (purine to purine or pyrimidine to pyrimidine) and transversion (purine to pyrimidine or vice versa). Insertions or deletions (indels) of a small number of bases can shift the reading frame if not in multiples of three. The functional impact varies widely depending on location and nature of the change.

Classification by effect: Synonymous (silent) mutations change a codon without altering the amino acid due to degeneracy of the genetic code; they may nonetheless affect translation efficiency or mRNA stability. Missense mutations substitute one amino acid for another; effects depend on whether the change disrupts active sites, structural stability or interaction surfaces. Nonsense mutations convert a sense codon to a stop codon, causing premature termination and often producing truncated, nonfunctional proteins. Frameshift mutations from indels alter the reading frame downstream, typically generating aberrant proteins with early stops. Mutations in regulatory sequences (promoters, enhancers, splice sites) can alter gene expression without changing protein coding sequence.

Chromosomal rearrangements and large-scale changes: Larger mutations include duplications, deletions, inversions and translocations of chromosome segments. These can disrupt gene structure, create fusion genes (as in some cancers), or alter gene dosage. Aneuploidy (gain or loss of whole chromosomes) has severe developmental consequences and is often lethal or associated with disorders such as Down syndrome.

Consequences for organisms and populations: Many mutations are neutral or deleterious; rarely, mutations confer selective advantages and drive evolution. In medical contexts, inherited mutations underlie genetic disorders, while somatic mutations contribute to cancer development by activating oncogenes or disabling tumour suppressors. Detecting and classifying mutations using sequencing forms the basis for genetic diagnosis, personalised medicine and population genetics studies.

Detection and practical considerations: Mutations are detected by sequencing, PCR-based assays, restriction fragment length polymorphism analysis, or by phenotypic screens. Functional assays often required to determine the effect of a mutation on protein activity or cellular phenotype. Understanding mutation mechanisms also informs prevention and treatment—for example, preventing UV exposure reduces thymine dimer formation, and knowledge about DNA repair defects guides cancer therapy choices.

Continuous threat and need for repair: DNA is subject to constant damage from endogenous metabolic by-products (reactive oxygen species, spontaneous hydrolysis), replication errors, and exogenous agents like UV and chemical mutagens. Efficient repair systems are essential to maintain genome integrity, prevent mutations and avoid cell death. Cells have evolved multiple complementary repair pathways tailored to different types of damage.

Direct repair: Some lesions can be directly reversed without replacing bases. Photoreactivation, found in many organisms but not placental mammals, uses photolyase enzymes to split UV-induced thymine dimers using light energy. O6-alkylguanine-DNA alkyltransferase transfers alkyl groups from modified guanine to a cysteine residue in the enzyme, restoring the base; the enzyme is consumed in the process.

Base excision repair (BER): BER corrects small, non-helix-distorting base lesions such as oxidised or deaminated bases. A DNA glycosylase recognises and removes the damaged base, creating an abasic site. An AP endonuclease cleaves the backbone, and DNA polymerase fills in the single-nucleotide gap (short-patch BER) or a few nucleotides (long-patch BER) with ligase sealing the nick. BER is essential for repairing oxidative damage and maintaining mitochondrial DNA.

Nucleotide excision repair (NER): NER removes bulky helix-distorting lesions like UV-induced thymine dimers and adducts from chemical carcinogens. Damage is recognised by multi-protein complexes that unwind the DNA, excise a short oligonucleotide segment containing the lesion, and allow DNA polymerase and ligase to synthesise and seal the replacement strand. Defects in NER cause disorders like xeroderma pigmentosum, characterised by extreme UV sensitivity and cancer predisposition.

Mismatch repair (MMR): MMR corrects replication errors such as base-base mismatches and small insertion-deletion loops that escape polymerase proofreading. The system recognises the newly synthesised strand (by nicks or methylation markers in bacteria), excises a patch around the mismatch, and resynthesises the correct sequence. MMR deficiency leads to high mutation rates and is implicated in certain hereditary cancers (e.g., Lynch syndrome) exhibiting microsatellite instability.

Double-strand break repair: Double-strand breaks (DSBs) are particularly hazardous. Two major repair pathways operate: non-homologous end joining (NHEJ) ligates broken ends directly and can be error-prone, leading to small insertions/deletions; homologous recombination (HR) uses an intact homologous sequence — typically a sister chromatid — to accurately repair the break, making it largely error-free but restricted to S/G2 phases when a template is available. Proteins like Ku, DNA-PK and Ligase IV mediate NHEJ, while RAD51 and BRCA1/2 are essential for HR. Defects in HR (BRCA mutations) predispose to breast and ovarian cancers.

Clinical and biotechnological relevance: DNA repair pathways influence ageing, cancer susceptibility and responses to therapy. Many cancer treatments induce DNA damage; tumour cells with defective repair are more sensitive to such treatments. Conversely, inhibitors of specific repair proteins (PARP inhibitors in BRCA-deficient tumors) exploit synthetic lethality for targeted therapy. Knowledge of repair mechanisms is also crucial when performing genome editing, as repair pathway choice determines the outcome of targeted DNA breaks introduced by tools like CRISPR-Cas9.

Conceptual framework: Recombinant DNA technology allows scientists to join DNA fragments from different sources to form new combinations that can be propagated in host organisms. Cloning a gene usually means inserting it into a vector — a DNA molecule capable of autonomous replication — and introducing this recombinant vector into a host cell where the DNA is copied and possibly expressed. This foundational method enables gene characterisation, protein production, functional studies and applications in medicine and industry.

Vectors and essential features: Common vectors include plasmids, bacteriophages, cosmids and artificial chromosomes. Useful features of vectors are an origin of replication (to ensure propagation), selectable markers (e.g., antibiotic resistance to identify cells that carry the vector), and a multiple cloning site (MCS) containing unique restriction enzyme sites for inserting foreign DNA. Expression vectors include additional elements such as promoters, ribosome binding sites or polyadenylation signals to drive transcription and translation of an inserted gene.

Restriction enzymes and ligation: Restriction endonucleases cut DNA at specific palindromic sequences producing blunt or cohesive (sticky) ends. By cutting both vector and insert with compatible enzymes, complementary ends can anneal and be covalently linked by DNA ligase, creating a stable recombinant molecule. Careful choice of enzymes and orientation considerations are important when designing a clone to express a protein in-frame with tags or regulatory sequences.

Transformation, selection and screening: The recombinant vector is introduced into host cells (e.g., E. coli) by transformation methods such as heat shock or electroporation. Selective growth on antibiotic-containing media ensures only cells carrying the plasmid survive. Screening is required to distinguish clones with desired inserts from those with empty vectors; methods include colony PCR, restriction mapping, and blue-white screening where insertion disrupts lacZ leading to white colonies on X-gal plates.

Expression and protein production: To produce recombinant proteins, the gene is cloned into an expression vector with appropriate promoter and host-specific regulatory elements. Hosts range from bacteria for simple proteins, to yeast, insect or mammalian cells for complex proteins requiring post-translational modifications. Inducible promoters allow controlled expression to avoid toxicity or inclusion body formation. Purification tags (His-tag, GST) facilitate downstream protein purification.

Ethical and safety considerations: Recombinant DNA work follows biosafety rules to prevent accidental release and ensure ethical use. Containment levels depend on vector and host used, and institutional approvals are required for work with certain organisms or clinical materials. Understanding cloning basics empowers biotechnology work while emphasising responsibility and regulatory compliance.

Principle and power: PCR (Polymerase Chain Reaction) is a method to amplify a specific DNA segment exponentially in vitro. Starting from minute amounts of template, repeated thermal cycles of denaturation, primer annealing and extension by a thermostable DNA polymerase yield millions to billions of copies in a short time. PCR revolutionised molecular biology because it enables sensitive detection, cloning, sequencing and analysis of DNA from tiny samples.

Essential components: PCR requires template DNA, two synthetic oligonucleotide primers complementary to flanking sequences defining the target, dNTPs, Mg2+ as a cofactor, buffer and a thermostable DNA polymerase (e.g., Taq polymerase). Thermal cycling includes: denaturation (~94–98°C) to separate DNA strands, annealing (typically 45–65°C depending on primer Tm) for primers to hybridise, and extension (72°C for Taq) where polymerase elongates primers to synthesise new DNA.

Primer design and optimisation: Effective primers are usually 18–25 bases with balanced GC content (40–60%), minimal secondary structure and little complementarity at 3' ends to avoid primer-dimers. Melting temperature (Tm) helps set annealing temperature. Optimization includes adjusting Mg2+ concentration, primer concentration and annealing temperature to improve specificity. Hot-start enzymes or modification of reaction setup reduce non-specific amplification.

Variants and specialised PCRs: Reverse transcription PCR (RT-PCR) converts RNA into complementary DNA (cDNA) using reverse transcriptase and then amplifies it; it is used to detect RNA viruses or measure gene expression. Quantitative PCR (qPCR or real-time PCR) monitors amplification in real time with fluorescent dyes (SYBR Green) or sequence-specific probes (TaqMan) to quantify starting material and compare expression across samples. Multiplex PCR amplifies several targets in one reaction using multiple primer pairs. High-fidelity polymerases (with proofreading) reduce error rates for cloning and sequencing applications.

Applications and limitations: PCR is central in diagnostics (pathogen detection), forensic identification, cloning, genotyping and environmental testing. However, PCR is sensitive to contamination — tiny amounts of template can cause false positives — and polymerase errors can introduce mutations. Appropriate controls (no-template controls, positive controls), clean technique, and confirmation by sequencing or orthogonal methods are essential. PCR cannot amplify across very long fragments easily without specialized enzymes and optimisation, and complex templates with high GC content may be challenging.

Quantitative considerations: Under ideal conditions the amount of product doubles each cycle, giving an exponential relationship: after n cycles, 2^n copies of starting template (per starting molecule) theoretically. Practical yields plateau due to reagent depletion, enzyme instability and product re-annealing; qPCR measures the cycle threshold (Ct) where fluorescence rises above background to estimate starting copy number relative to standards.

Principle of separation: Gel electrophoresis separates nucleic acid (or protein) molecules by size and, to some extent, shape, by applying an electric field across a porous gel matrix. DNA and RNA are negatively charged due to their phosphate backbones, so they migrate toward the positive electrode. The gel (commonly agarose for nucleic acids, polyacrylamide for high-resolution separations) acts as a molecular sieve: smaller fragments navigate pores more easily and therefore travel farther in a given time than larger fragments.

Agarose gel properties and preparation: Agarose concentration determines resolving power: low percentage gels (0.5–1%) are used for large fragments (kilobase pairs), while higher percentage gels (1.5–2.5%) resolve smaller fragments. Gels are cast in buffers (TAE or TBE) that conduct current and maintain pH. Wells are formed for loading samples blended with loading dye to increase density and visualise progress. Electrophoresis voltage affects resolution and run time; too high voltage produces heat and band distortion.

Staining and detection: After electrophoresis, nucleic acids are visualised by staining with intercalating dyes that bind DNA and fluoresce under UV or blue light. Ethidium bromide was historically used but is mutagenic; safer alternatives like SYBR Safe or GelRed are available. Visualization requires a transilluminator or gel documentation system. DNA size is estimated by running a standard ladder (molecular weight marker) alongside samples.

Applications and workflows: Gel electrophoresis is used to check PCR products, verify restriction digests, analyse plasmid preparations, separate fragments for cloning, and assess RNA integrity (denaturing gels or Bioanalyzer systems). Bands of interest can be excised from agarose gels and DNA purified for downstream applications like sequencing or ligation. Polyacrylamide gels offer higher resolution for small fragments (e.g., single-base differences) and are used in sequencing or SNP analysis.

Quantitation and considerations: Band intensity can provide semi-quantitative information about DNA amount when compared to standards, though staining efficiency and imaging conditions affect accuracy. Factors influencing results include buffer composition, gel percentage, running conditions, and sample purity. Care when handling UV light and some stains is necessary for safety; alternatives such as blue-light imaging and non-toxic dyes reduce hazards.

Troubleshooting common issues: Smearing often indicates degraded samples, overloaded wells, or running the gel too hot. No bands could result from failed PCR, missing DNA, or issues in loading. Unexpected band sizes may reflect primer-dimers, non-specific amplification, or partial digestion. Clear understanding of the method helps interpret results and prepare samples correctly for downstream molecular biology techniques.

Importance of sequencing: Determining the exact order of nucleotides in DNA allows identification of genes, detection of mutations, comparison of genomes and insights into evolutionary relationships. Sequencing underlies diagnostics, research and biotechnology, enabling personalised medicine and pathogen surveillance.

Sanger (chain-termination) sequencing: Classical Sanger sequencing relies on a DNA polymerase extending a primer in the presence of normal deoxynucleotides (dNTPs) and a small proportion of chain-terminating dideoxynucleotides (ddNTPs) lacking a 3'-OH. Incorporation of a ddNTP halts extension, producing fragments of varying lengths ending at each occurrence of that base. By labelling ddNTPs with different fluorescent dyes and separating fragments by capillary electrophoresis, an automated sequencer reads the dye signals to reconstruct the sequence. Sanger sequencing yields accurate reads up to ~700–1000 bases and is widely used for validation and small-scale projects.

Next-generation sequencing (NGS): NGS technologies massively parallelise sequencing, producing millions to billions of short reads in a single run. Platforms vary (sequencing-by-synthesis, sequencing-by-ligation, nanopore sequencing) and differ in read length, accuracy and throughput. NGS enables whole-genome sequencing, exome sequencing, RNA-seq for transcriptome profiling, ChIP-seq for protein-DNA interaction mapping, and targeted deep sequencing to detect low-frequency variants. Data analysis is computationally intensive and involves quality control, trimming, alignment to a reference genome or de novo assembly, and variant calling.

Data analysis and interpretation: Raw sequencing reads must be assessed for quality scores, trimmed to remove adapters and low-quality ends, and aligned to a reference genome using algorithms that handle mismatches and indels. Variant calling identifies single nucleotide variants (SNVs), insertions/deletions (indels) and structural variants; annotation links variants to genes and predicts functional effects (synonymous, missense, nonsense). Depth of coverage and read quality influence confidence: higher coverage gives greater sensitivity for detecting rare variants.

Applications and considerations: Sequencing is used for diagnosing genetic disorders, guiding cancer therapy by identifying driver mutations, tracing pathogen outbreaks by genomic epidemiology, and studying population genetics. Ethical issues include data privacy, incidental findings and consent. Technical limitations include challenges in resolving repetitive regions, structural variants, and phasing haplotypes; long-read technologies and hybrid approaches help address these gaps. Validation by orthogonal methods (Sanger sequencing, qPCR) is common for clinically important findings.

Purpose and principle: Blotting techniques transfer biomolecules separated by electrophoresis onto a stable membrane for detection with specific probes. Each type of blot targets a class of molecules: Southern for DNA, Northern for RNA and Western for proteins. Blots reveal the presence, size and relative abundance of targets and are essential for validating cloning, expression and detecting specific sequences or proteins.

Southern blotting (DNA): In a Southern blot, genomic or digested DNA is separated by agarose gel electrophoresis and then transferred to a nylon or nitrocellulose membrane by capillary action, vacuum or electrotransfer. The membrane-bound DNA is denatured and hybridised with a labelled single-stranded DNA probe complementary to the target sequence. Detection of bound probe indicates presence and size of matching fragments; Southern blots are used to confirm gene presence, copy number, or to map restriction sites.

Northern blotting (RNA): Northern blot transfers RNA separated by denaturing agarose gel to a membrane and hybridises it with a labelled probe. Because RNA retains size information, Northern blots reveal transcript length, alternative splicing forms, and relative transcript abundance between samples. Unlike qPCR, Northern blotting directly shows transcript size and can detect transcript isoforms, though it is less sensitive and more labour-intensive than some modern methods.

Western blotting (protein): Western blot uses SDS-PAGE to separate proteins by size, transfers them to a membrane, and detects specific proteins using antibodies. Primary antibodies recognise the target protein; secondary antibodies conjugated to enzymes or fluorophores enable signal amplification and detection (chemiluminescence or fluorescence). Western blots confirm protein expression, estimate molecular weight and can detect post-translational modifications using modification-specific antibodies.

Probes, labels and detection sensitivity: Probes may be radioactively labelled (historically common for high sensitivity) or labelled with non-radioactive tags like biotin, digoxigenin, fluorescent dyes or enzymes that produce luminescent signals. Choice depends on sensitivity needed, safety and equipment available. Controls such as loading controls (housekeeping genes for Northern, actin or tubulin for Western) ensure that observed differences reflect real biological changes.

Applications and limitations: Blotting is used to validate gene cloning, assess expression changes, detect alternative splicing, confirm protein production and study post-translational changes. Limitations include labour intensity, need for good probes/antibodies, and lower throughput compared with sequencing or mass spectrometry. Despite newer high-throughput methods, blotting remains a reliable technique for many molecular validation tasks.

Medical diagnostics and therapy: Molecular biology provides tools for precise diagnosis and targeted treatment. PCR-based tests detect pathogen DNA/RNA rapidly and sensitively, enabling early diagnosis and monitoring of infectious diseases. Sequencing identifies genetic variants responsible for inherited disorders, guiding diagnosis and counselling. In cancer, genomic profiling reveals driver mutations that inform targeted therapies. Gene therapy aims to correct defective genes by delivering functional copies or editing genomes using CRISPR/Cas systems. Monoclonal antibodies and recombinant proteins (insulin, clotting factors) are products of molecular cloning and expression technologies used widely in medicine.

Agriculture and food security: Genetic engineering produces crops with desirable traits: pest resistance (e.g., Bt crops), herbicide tolerance, improved nutritional content (e.g., Golden Rice), and enhanced stress tolerance. Molecular markers and marker-assisted selection accelerate breeding by tracking beneficial alleles. Biotechnology also enables production of biofertilisers, biopesticides and microbes for soil health. Regulatory and biosafety assessment ensures environmental and food safety before commercial release.

Industrial biotechnology: Recombinant microbes and enzymes are used in manufacturing pharmaceuticals, enzymes for detergents, fermentation-based production of biofuels, and bioconversion of waste into valuable products. Metabolic engineering optimises microbial pathways to increase yields of desired compounds. Synthetic biology combines modular parts to design new biosynthetic pathways and organisms for specific industrial tasks.

Forensics and public health: DNA profiling using short tandem repeats (STRs) or mitochondrial markers is a powerful forensic tool for identity verification, paternity testing and wildlife crime investigation. Genomic epidemiology uses sequencing to trace pathogen transmission and evolution during outbreaks, informing public health responses. Environmental DNA (eDNA) detection monitors biodiversity and invasive species without direct sampling of organisms.

Emerging technologies and ethical issues: CRISPR-based genome editing allows precise modifications in organisms and holds promise for treating genetic disorders, developing disease-resistant crops and creating research models. However, ethical concerns arise over germline editing, ecological impacts of modified organisms, equitable access to technologies, and data privacy in genomics. Responsible governance, regulatory frameworks and public dialogue are essential to harness benefits while managing risks.

Education and workforce impact: Mastery of molecular biology techniques is critical for modern biotechnology careers. Skills in PCR, cloning, sequencing, bioinformatics and data interpretation are in demand. Understanding the applications and limitations of molecular tools helps students evaluate claims, contribute to innovation and participate in informed discussions about the societal implications of biotechnology.